US biotech company extends lease of PExA instruments

PExA has signed an extension agreement with the American biotech company that has been renting a PExA instrument since October last year.

On August 16, 2022, PExA announced the signing of an agreement with a US biotech company in California. After installation and training on site in South San Francisco last October, the company has been using the PExA 2.1 instrument for almost a year for non-invasive sampling from the small airways. An extension agreement for another three months has now been signed.

Tomas Gustafsson, CEO of PExA comments

It is very exciting that large pharmaceutical companies use our instrument, it shows both how unique our product is and the trust that we as a small company have managed to create for our technology. We are particularly pleased that this innovative biotech company, with which we feel we have developed a close relationship, has now chosen to extend its agreement with us.

The order value for the extension is approximately 110,000 SEK.

Source: Vikingen.se

About the Viking

With Viking’s signals, you have a good chance of finding the winners and selling in time. There are many securities. With Viking’s autopilots, price data, tables and stock prices, you can sort out the most interesting ETFs, shares, options, warrants, funds, etc.

Click here to see what Vikingen offers: Detailed comparison – Stock market program for those who want to become even richer (vikingen.se)